ID   NMDE4_RAT               Reviewed;        1323 AA.
AC   Q62645; Q63381; Q63382; Q63729; Q63730;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   29-AUG-2001, sequence version 2.
DT   02-OCT-2024, entry version 198.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2D;
DE            Short=GluN2D;
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-4;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2D;
DE            Short=NMDAR2D;
DE            Short=NR2D;
DE   Flags: Precursor;
GN   Name=Grin2d; Synonyms=GluN2D;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1265-1356 (ISOFORM 2).
RC   STRAIN=Sprague-Dawley; TISSUE=Forebrain;
RX   PubMed=8428958; DOI=10.1016/s0021-9258(18)53849-7;
RA   Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M.,
RA   Akazawa C., Shigemoto R., Mizuno N., Masu M., Nakanishi S.;
RT   "Molecular characterization of the family of the N-methyl-D-aspartate
RT   receptor subunits.";
RL   J. Biol. Chem. 268:2836-2843(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=7512349; DOI=10.1016/0896-6273(94)90210-0;
RA   Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H.;
RT   "Developmental and regional expression in the rat brain and functional
RT   properties of four NMDA receptors.";
RL   Neuron 12:529-540(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Boulter J., Pecht G.;
RL   Submitted (MAR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   INTERACTION WITH DLG4.
RX   PubMed=7569905; DOI=10.1126/science.7569905;
RA   Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H.;
RT   "Domain interaction between NMDA receptor subunits and the postsynaptic
RT   density protein PSD-95.";
RL   Science 269:1737-1740(1995).
RN   [5]
RP   INTERACTION WITH PATJ.
RX   PubMed=9647694; DOI=10.1006/mcne.1998.0679;
RA   Kurschner C., Mermelstein P.G., Holden W.T., Surmeier D.J.;
RT   "CIPP, a novel multivalent PDZ domain protein, selectively interacts with
RT   Kir4.0 family members, NMDA receptor subunits, neurexins, and
RT   neuroligins.";
RL   Mol. Cell. Neurosci. 11:161-172(1998).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 424-827 IN COMPLEXES WITH
RP   GLUTAMATE AND N-METHYL-D-ASPARTATE, FUNCTION, SUBUNIT, SUBCELLULAR
RP   LOCATION, AND DISULFIDE BONDS.
RX   PubMed=21522138; DOI=10.1038/ncomms1295;
RA   Vance K.M., Simorowski N., Traynelis S.F., Furukawa H.;
RT   "Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors.";
RL   Nat. Commun. 2:294-294(2011).
RN   [7] {ECO:0007744|PDB:4JWY}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 424-564 AND 632-825 IN COMPLEX
RP   WITH GRIN1, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=23625947; DOI=10.1124/mol.113.085803;
RA   Hansen K.B., Tajima N., Risgaard R., Perszyk R.E., Jorgensen L.,
RA   Vance K.M., Ogden K.K., Clausen R.P., Furukawa H., Traynelis S.F.;
RT   "Structural determinants of agonist efficacy at the glutamate binding site
RT   of N-methyl-D-aspartate receptors.";
RL   Mol. Pharmacol. 84:114-127(2013).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium. Channel
CC       activation requires binding of the neurotransmitter glutamate to the
CC       epsilon subunit, glycine binding to the zeta subunit, plus membrane
CC       depolarization to eliminate channel inhibition by Mg(2+)
CC       (PubMed:21522138, PubMed:23625947, PubMed:7512349). Sensitivity to
CC       glutamate and channel kinetics depend on the subunit composition
CC       (PubMed:23625947, PubMed:7512349). {ECO:0000269|PubMed:21522138,
CC       ECO:0000269|PubMed:23625947, ECO:0000269|PubMed:7512349, ECO:0000305}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed of
CC       two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A, GRIN2B,
CC       GRIN2C or GRIN2D) (in vitro) (PubMed:21522138, PubMed:23625947). In
CC       vivo, the subunit composition may depend on the expression levels of
CC       the different subunits (Probable). Interacts with PDZ domains of PATJ
CC       and DLG4 (PubMed:7569905, PubMed:9647694).
CC       {ECO:0000269|PubMed:21522138, ECO:0000269|PubMed:23625947,
CC       ECO:0000269|PubMed:7569905, ECO:0000269|PubMed:9647694, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q62645; Q63ZW7: Patj; Xeno; NbExp=3; IntAct=EBI-631067, EBI-8366894;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21522138,
CC       ECO:0000269|PubMed:23625947, ECO:0000269|PubMed:7512349}; Multi-pass
CC       membrane protein {ECO:0000305}. Postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=Q62645-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q62645-2; Sequence=VSP_000136;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, mainly in the subcortical
CC       region.
CC   -!- DEVELOPMENTAL STAGE: Already detected in embryonic stages, peaks at
CC       postnatal day 7, and decreases thereafter to adult levels.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of a
CC       transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:Q00960}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. NR2D/GRIN2D subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13213; BAA02500.1; -; mRNA.
DR   EMBL; D13214; BAA02501.1; -; mRNA.
DR   EMBL; L31611; AAC37646.1; -; mRNA.
DR   EMBL; L31612; AAC37647.1; -; mRNA.
DR   EMBL; U08260; AAA17833.1; -; mRNA.
DR   PIR; I78557; I78557.
DR   RefSeq; NP_073634.1; NM_022797.1. [Q62645-1]
DR   RefSeq; XP_008757539.1; XM_008759317.2.
DR   PDB; 3OEK; X-ray; 1.90 A; A=424-564, A=686-827.
DR   PDB; 3OEL; X-ray; 1.90 A; A=424-564, A=686-827.
DR   PDB; 3OEM; X-ray; 1.90 A; A=424-564, A=686-827.
DR   PDB; 3OEN; X-ray; 1.80 A; A=424-564, A=686-827.
DR   PDB; 4JWY; X-ray; 2.00 A; A=424-564, A=686-827.
DR   PDBsum; 3OEK; -.
DR   PDBsum; 3OEL; -.
DR   PDBsum; 3OEM; -.
DR   PDBsum; 3OEN; -.
DR   PDBsum; 4JWY; -.
DR   AlphaFoldDB; Q62645; -.
DR   SMR; Q62645; -.
DR   BioGRID; 246577; 3.
DR   ComplexPortal; CPX-288; NMDA receptor complex, GluN1-GluN2D.
DR   IntAct; Q62645; 4.
DR   MINT; Q62645; -.
DR   STRING; 10116.ENSRNOP00000075255; -.
DR   BindingDB; Q62645; -.
DR   ChEMBL; CHEMBL303; -.
DR   DrugCentral; Q62645; -.
DR   GuidetoPHARMACOLOGY; 459; -.
DR   GlyCosmos; Q62645; 7 sites, No reported glycans.
DR   GlyGen; Q62645; 7 sites.
DR   iPTMnet; Q62645; -.
DR   PhosphoSitePlus; Q62645; -.
DR   PaxDb; 10116-ENSRNOP00000028615; -.
DR   Ensembl; ENSRNOT00000028615.5; ENSRNOP00000028615.4; ENSRNOG00000021063.5. [Q62645-1]
DR   Ensembl; ENSRNOT00055010982; ENSRNOP00055008566; ENSRNOG00055006719. [Q62645-1]
DR   Ensembl; ENSRNOT00060018778; ENSRNOP00060014644; ENSRNOG00060011093. [Q62645-1]
DR   Ensembl; ENSRNOT00065054925; ENSRNOP00065045186; ENSRNOG00065031882. [Q62645-1]
DR   GeneID; 24412; -.
DR   KEGG; rno:24412; -.
DR   UCSC; RGD:2740; rat. [Q62645-1]
DR   AGR; RGD:2740; -.
DR   CTD; 2906; -.
DR   RGD; 2740; Grin2d.
DR   eggNOG; KOG1053; Eukaryota.
DR   GeneTree; ENSGT00940000159109; -.
DR   HOGENOM; CLU_002039_3_1_1; -.
DR   InParanoid; Q62645; -.
DR   OMA; DRWRRPK; -.
DR   OrthoDB; 1034721at2759; -.
DR   PhylomeDB; Q62645; -.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   Reactome; R-RNO-9609736; Assembly and cell surface presentation of NMDA receptors.
DR   EvolutionaryTrace; Q62645; -.
DR   PRO; PR:Q62645; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000021063; Expressed in testis and 13 other cell types or tissues.
DR   ExpressionAtlas; Q62645; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IDA:SynGO.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; TAS:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; NAS:ComplexPortal.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0016595; F:glutamate binding; IMP:RGD.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:glutamate-gated receptor activity; IDA:RGD.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0005261; F:monoatomic cation channel activity; IDA:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0022843; F:voltage-gated monoatomic cation channel activity; IMP:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISS:UniProtKB.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IMP:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IBA:GO_Central.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IBA:GO_Central.
DR   GO; GO:0098655; P:monoatomic cation transmembrane transport; IDA:ComplexPortal.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:ComplexPortal.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IDA:ComplexPortal.
DR   GO; GO:1904062; P:regulation of monoatomic cation transmembrane transport; IDA:ComplexPortal.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; NAS:ComplexPortal.
DR   GO; GO:0051930; P:regulation of sensory perception of pain; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IMP:RGD.
DR   CDD; cd06378; PBP1_iGluR_NMDA_NR2; 1.
DR   CDD; cd13718; PBP2_iGluR_NMDA_Nr2; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.40.190.10; Periplasmic binding protein-like II; 2.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_Glu_rcpt_met.
DR   InterPro; IPR015683; Ionotropic_Glu_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR18966:SF385; GLUTAMATE RECEPTOR IONOTROPIC, NMDA 2D; 1.
DR   PANTHER; PTHR18966; IONOTROPIC GLUTAMATE RECEPTOR; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF53850; Periplasmic binding protein-like II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Magnesium; Membrane; Methylation; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..1323
FT                   /note="Glutamate receptor ionotropic, NMDA 2D"
FT                   /id="PRO_0000011585"
FT   TOPO_DOM        28..581
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        582..600
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        601..627
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   INTRAMEM        628..647
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        648..654
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        655..670
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        671..841
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        842..861
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        862..1323
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   REGION          628..647
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   REGION          897..952
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          977..1112
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1201..1323
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1321..1323
FT                   /note="PDZ-binding"
FT   COMPBIAS        899..930
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1016..1033
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1077..1096
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1213..1243
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         536..538
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:21522138,
FT                   ECO:0007744|PDB:3OEL, ECO:0007744|PDB:3OEN"
FT   BINDING         538
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   BINDING         543
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:21522138,
FT                   ECO:0007744|PDB:3OEL, ECO:0007744|PDB:3OEN"
FT   BINDING         714..715
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:21522138,
FT                   ECO:0007744|PDB:3OEL, ECO:0007744|PDB:3OEN"
FT   BINDING         756
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:21522138,
FT                   ECO:0007744|PDB:3OEL, ECO:0007744|PDB:3OEN"
FT   SITE            639
FT                   /note="Functional determinant of NMDA receptors"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1303
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03391"
FT   MOD_RES         1313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03391"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        349
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        363
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        381
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        464
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        566
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        712
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        101..345
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   DISULFID        452..480
FT                   /evidence="ECO:0000269|PubMed:21522138"
FT   DISULFID        459..481
FT                   /evidence="ECO:0000269|PubMed:21522138"
FT   DISULFID        770..825
FT                   /evidence="ECO:0000269|PubMed:21522138"
FT   VAR_SEQ         1265..1323
FT                   /note="CPRAAPTRRLTGPSRHARRCPHAAHWGPPLPTASHRRHRGGDLGTRRGSAHF
FT                   SSLESEV -> RPCPPHRTGDTGAGTWAHAGALRISPAWSPRYDAAPAPTPTPAAPSVS
FT                   AGHGPRGRAKWTGPSWVGKDRNGPGRTPPGAASCAPTPFALGEL (in isoform
FT                   1)"
FT                   /evidence="ECO:0000303|PubMed:8428958"
FT                   /id="VSP_000136"
FT   CONFLICT        25
FT                   /note="A -> V (in Ref. 3; AAA17833)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="P -> Q (in Ref. 3; AAA17833)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        67
FT                   /note="G -> V (in Ref. 2; AAC37646)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        94
FT                   /note="R -> P (in Ref. 2; AAC37646/AAC37647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305
FT                   /note="R -> A (in Ref. 2; AAC37646/AAC37647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        635
FT                   /note="A -> G (in Ref. 3; AAA17833)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        974
FT                   /note="E -> D (in Ref. 3; AAA17833)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1253
FT                   /note="A -> G (in Ref. 3; AAA17833)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1266..1267
FT                   /note="PR -> TT (in Ref. 3; AAA17833)"
FT                   /evidence="ECO:0000305"
FT   STRAND          428..433
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   TURN            437..439
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          440..444
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   TURN            447..449
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          457..463
FT                   /evidence="ECO:0007829|PDB:3OEK"
FT   STRAND          478..483
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           484..496
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          499..504
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          507..510
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           520..526
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          529..533
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           541..544
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          547..549
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          554..563
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           693..696
FT                   /evidence="ECO:0007829|PDB:3OEK"
FT   HELIX           698..700
FT                   /evidence="ECO:0007829|PDB:3OEK"
FT   STRAND          701..703
FT                   /evidence="ECO:0007829|PDB:3OEK"
FT   HELIX           714..722
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           724..730
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           731..733
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           738..746
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          751..756
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           757..766
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           768..770
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          772..774
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           775..778
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          781..786
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   STRAND          789..791
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           797..809
FT                   /evidence="ECO:0007829|PDB:3OEN"
FT   HELIX           812..821
FT                   /evidence="ECO:0007829|PDB:3OEN"
SQ   SEQUENCE   1323 AA;  143101 MW;  40F7D60192579564 CRC64;
     MRGAGGPRGP RGPAKMLLLL ALACASPFPE EVPGPGAVGG GTGGARPLNV ALVFSGPAYA
     AEAARLGPAV AAAVRSPGLD VRPVALVLNG SDPRSLVLQL CDLLSGLRVH GVVFEDDSRA
     PAVAPILDFL SAQTSLPIVA VHGGAALVLT PKEKGSTFLQ LGSSTEQQLQ VIFEVLEEYD
     WTSFVAVTTR APGHRAFLSY IEVLTDGSLV GWEHRGALTL DPGAGEAVLG AQLRSVSAQI
     RLLFCAREEA EPVFRAAEEA GLTGPGYVWF MVGPQLAGGG GSGVPGEPLL LPGGSPLPAG
     LFAVRSAGWR DDLARRVAAG VAVVARGAQA LLRDYGFLPE LGHDCRTQNR THRGESLHRY
     FMNITWDNRD YSFNEDGFLV NPSLVVISLT RDRTWEVVGS WEQQTLRLKY PLWSRYGRFL
     QPVDDTQHLT VATLEERPFV IVEPADPISG TCIRDSVPCR SQLNRTHSPP PDAPRPEKRC
     CKGFCIDILK RLAHTIGFSY DLYLVTNGKH GKKIDGVWNG MIGEVFYQRA DMAIGSLTIN
     EERSEIVDFS VPFVETGISV MVARSNGTVS PSAFLEPYSP AVWVMMFVMC LTVVAVTVFI
     FEYLSPVGYN RSLATGKRPG GSTFTIGKSI WLLWALVFNN SVPVENPRGT TSKIMVLVWA
     FFAVIFLASY TANLAAFMIQ EEYVDTVSGL SDRKFQRPQE QYPPLKFGTV PNGSTEKNIR
     SNYPDMHSYM VRYNQPRVEE ALTQLKAGKL DAFIYDAAVL NYMARKDEGC KLVTIGSGKV
     FATTGYGIAL HKGSRWKRPI DLALLQFLGD DEIEMLERLW LSGICHNDKI EVMSSKLDID
     NMAGVFYMLL VAMGLSLLVF AWEHLVYWRL RHCLGPTHRM DFLLAFSRGM YSCCSAEAAP
     PPAKPPPPPQ PLPSPAYPAA RPPPGPAPFV PRERAAADRW RRAKGTGPPG GAAIADGFHR
     YYGPIEPQGL GLGEARAAPR GAAGRPLSPP TTQPPQKPPP SYFAIVREQE PTEPPAGAFP
     GFPSPPAPPA AAAAAVGPPL CRLAFEDESP PAPSRWPRSD PESQPLLGGG AGGPSAGAPT
     APPPRRAAPP PCAYLDLEPS PSDSEDSESL GGASLGGLEP WWFADFPYPY AERLGPPPGR
     YWSVDKLGGW RAGSWDYLPP RGGPAWHCRH CASLELLPPP RHLSCSHDGL DGGWWAPPPP
     PWAAGPPPRR RARCGCPRPH PHRPRASHRA PAAAPHHHRH RRAAGGWDFP PPAPTSRSLE
     DLSSCPRAAP TRRLTGPSRH ARRCPHAAHW GPPLPTASHR RHRGGDLGTR RGSAHFSSLE
     SEV
//
